OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Quality control and removal of technical variation of NMR metabolic biomarker data in ~120,000 UK Biobank participants
Scott C. Ritchie, Praveen Surendran, Savita Karthikeyan, et al.
Scientific Data (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK Biobank
Heli Julkunen, Anna Cichońska, Mika Tiainen, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 228

Genome-wide characterization of circulating metabolic biomarkers
Minna K. Karjalainen, Savita Karthikeyan, Clare Oliver‐Williams, et al.
Nature (2024) Vol. 628, Iss. 8006, pp. 130-138
Open Access | Times Cited: 79

An atlas of genetic scores to predict multi-omic traits
Yu Xu, Scott C. Ritchie, Yujian Liang, et al.
Nature (2023) Vol. 616, Iss. 7955, pp. 123-131
Open Access | Times Cited: 71

Studying Metabolism by NMR-Based Metabolomics
Sofia Moco
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 68

Plasma proteomic signatures of social isolation and loneliness associated with morbidity and mortality
Chun Shen, Ruohan Zhang, Jin‐Tai Yu, et al.
Nature Human Behaviour (2025)
Open Access | Times Cited: 2

SGLT2 inhibition, circulating metabolites, and atrial fibrillation: a Mendelian randomization study
Jiang Li, Yuefeng Yu, Ying Sun, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 25

Remnant Cholesterol, Not LDL Cholesterol, Explains Peripheral Artery Disease Risk Conferred by apoB: A Cohort Study
Benjamin Nilsson Wadström, Kasper Mønsted Pedersen, Anders Berg Wulff, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2024) Vol. 44, Iss. 5, pp. 1144-1155
Closed Access | Times Cited: 10

A metabolomic profile of biological aging in 250,341 individuals from the UK Biobank
Shiyu Zhang, Zheng Wang, Yijing Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10

Gut microbiota, circulating metabolites, and gallstone disease: a Mendelian randomization study
Xutao Hu, Qiu Binxu, Guang-zhao Shao, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 8

Association of metabolic signatures of air pollution with MASLD: Observational and Mendelian randomization study
Shanshan Ran, Jingyi Zhang, Fei Tian, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 8

Human genetics uncovers MAP3K15 as an obesity-independent therapeutic target for diabetes
Abhishek Nag, Ryan S. Dhindsa, Jonathan Mitchell, et al.
Science Advances (2022) Vol. 8, Iss. 46
Open Access | Times Cited: 23

Effects of protein-coding variants on blood metabolite measurements and clinical biomarkers in the UK Biobank
Abhishek Nag, Ryan S. Dhindsa, Lawrence Middleton, et al.
The American Journal of Human Genetics (2023) Vol. 110, Iss. 3, pp. 487-498
Open Access | Times Cited: 15

A genome-first approach to variants in MLXIPL and their association with hepatic steatosis and plasma lipids
Leonida Hehl, Kate Townsend Creasy, Cecilia Vitali, et al.
Hepatology Communications (2024) Vol. 8, Iss. 5
Open Access | Times Cited: 5

SGLT2 inhibition, high-density lipoprotein, and kidney function: a mendelian randomization study
Zhijuan Wang, Jie Wei, Wenman Zhao, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4

Harnessing Artificial Intelligence in Multimodal Omics Data Integration: Paving the Path for the Next Frontier in Precision Medicine
Yonghyun Nam, Jae‐Sik Kim, Sang‐Hyuk Jung, et al.
Annual Review of Biomedical Data Science (2024) Vol. 7, Iss. 1, pp. 225-250
Closed Access | Times Cited: 4

Metabolomic and genomic prediction of common diseases in 700,217 participants in three national biobanks
Jeffrey C. Barrett, Tõnu Esko, Krista Fischer, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4

Utilizing metabolomic profiling as a supportive diagnostic tool for radiologically isolated syndrome
Güllü Tarhan, Saime Füsun Domaç, Şahabettin Selek, et al.
Multiple Sclerosis and Related Disorders (2025) Vol. 94, pp. 106250-106250
Closed Access

Refinement of a Published Gene‐Physical Activity Interaction Impacting HDL‐Cholesterol: Role of Sex and Lipoprotein Subfractions
Kenneth E. Westerman, Tuomas O. Kilpeläinen, Magdalena Sevilla‐Gonzalez, et al.
Genetic Epidemiology (2025) Vol. 49, Iss. 1
Open Access

Machine learning and multi-omics in precision medicine for ME/CFS
Katherine Huang, Brett A. Lidbury, Natalie Thomas, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access

Multi-omic spatial effects on high-resolution AI-derived retinal thickness
Victoria E. Jackson, Yingli Wu, Roberto Bonelli, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access

Potential causal evidence for an ApoB-independent and HDL-related risk profile associated with coronary artery disease
Linjun Ao, Diana van Heemst, J. Wouter Jukema, et al.
Journal of Lipid Research (2025), pp. 100778-100778
Open Access

Page 1 - Next Page

Scroll to top